Newhall, Kathryn
Bristol-Myers Squibb (United States)
2 papers on CoChatORCID 0000-0002-6441-9316
Most cited papers
- Verified
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,430
- Verified
Multiplexed Immunofluorescence (IF) Analysis and Gene Expression Profiling of Biopsies from Patients with Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL) Treated with Lisocabtagene Maraleucel (liso-cel) in Transcend NHL 001 Reveal Patterns of Immune Infiltration Associated with Durable Response
Reiss, D. J., Do, T., Kuo, D., Gray, V. E., Olson, N. E., Lee, C.-W., Young, M. H., Srinivasan, S., Gray, F. D., Fox, B., et al. (2019) · Blood
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free